Feasibility of Dialysate Bolus-Based Absolute Blood Volume Estimation in Maintenance Hemodialysis Patients.
blood volume
chronic
chronic kidney disease
fluid status
hemodialysis
renal dialysis
renal insufficiency
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
24
10
2021
accepted:
04
01
2022
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
1
3
2022
Statut:
epublish
Résumé
Absolute blood volume (ABV) is a critical component of fluid status, which may inform target weight prescriptions and hemodynamic vulnerability of dialysis patients. Here, we utilized the changes in relative blood volume (RBV), monitored by ultrasound (BVM) upon intradialytic 240 mL dialysate fluid bolus-infusion 1 h after hemodialysis start, to calculate the session-specific ABV. With the main goal of assessing clinical feasibility, our sub-aims were to (i) standardize the BVM-data read-out; (ii) determine optimal time-points for ABV-calculation, "before-" and "after-bolus"; (iii) assess ABV-variation. We used high-level programming language and basic descriptive statistics in a retrospective study of routinely measured BVM-data from 274 hemodialysis sessions in 98 patients. Regarding (i) and (ii), we automatized the processing of RBV-data, and determined an algorithm to select the adequate RBV-data points for ABV-calculations. Regarding (iii), we found in 144 BVM-curves from 75 patients, that the average ABV ± standard deviation was 5.2 ± 1.5 L and that among those 51 patients who still had ≥2 valid estimates, the average intra-patient standard deviation in ABV was 0.8 L. Twenty-seven of these patients had an average intra-patient standard deviation in ABV <0.5 L. We demonstrate feasibility of ABV-calculation by an automated algorithm after dialysate bolus-administration, based on the BVM-curve. Based on our results from this simple "abridged" calculation approach with routine clinical measurements, we encourage the use of multi-compartment modeling and comparison with reference methods of ABV-determination. Hopes are high that clinicians will be able to use ABV to inform target weight prescription, improving hemodynamic stability.
Sections du résumé
BACKGROUND
BACKGROUND
Absolute blood volume (ABV) is a critical component of fluid status, which may inform target weight prescriptions and hemodynamic vulnerability of dialysis patients. Here, we utilized the changes in relative blood volume (RBV), monitored by ultrasound (BVM) upon intradialytic 240 mL dialysate fluid bolus-infusion 1 h after hemodialysis start, to calculate the session-specific ABV. With the main goal of assessing clinical feasibility, our sub-aims were to (i) standardize the BVM-data read-out; (ii) determine optimal time-points for ABV-calculation, "before-" and "after-bolus"; (iii) assess ABV-variation.
METHODS
METHODS
We used high-level programming language and basic descriptive statistics in a retrospective study of routinely measured BVM-data from 274 hemodialysis sessions in 98 patients.
RESULTS
RESULTS
Regarding (i) and (ii), we automatized the processing of RBV-data, and determined an algorithm to select the adequate RBV-data points for ABV-calculations. Regarding (iii), we found in 144 BVM-curves from 75 patients, that the average ABV ± standard deviation was 5.2 ± 1.5 L and that among those 51 patients who still had ≥2 valid estimates, the average intra-patient standard deviation in ABV was 0.8 L. Twenty-seven of these patients had an average intra-patient standard deviation in ABV <0.5 L.
CONCLUSIONS
CONCLUSIONS
We demonstrate feasibility of ABV-calculation by an automated algorithm after dialysate bolus-administration, based on the BVM-curve. Based on our results from this simple "abridged" calculation approach with routine clinical measurements, we encourage the use of multi-compartment modeling and comparison with reference methods of ABV-determination. Hopes are high that clinicians will be able to use ABV to inform target weight prescription, improving hemodynamic stability.
Identifiants
pubmed: 35223900
doi: 10.3389/fmed.2022.801089
pmc: PMC8866453
doi:
Types de publication
Journal Article
Langues
eng
Pagination
801089Informations de copyright
Copyright © 2022 Krenn, Schmiedecker, Schneditz, Hödlmoser, Mayer, Wassertheurer, Omic, Schernhammer, Wabel and Hecking.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nephrol Dial Transplant. 1998 Jul;13(7):1882-5
pubmed: 9681757
Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1831-1840
pubmed: 29018100
Eur J Appl Physiol. 2005 Dec;95(5-6):486-95
pubmed: 16222540
Ann Hematol. 2014 Jul;93(7):1159-65
pubmed: 24488226
Am Clin Lab. 1991 Jul;10(6):20-2
pubmed: 10148237
Kidney Int. 2021 Jun;99(6):1408-1417
pubmed: 33607178
Nephrol Dial Transplant. 2005 Oct;20(10):2043-9
pubmed: 16105867
Hemodial Int. 2014 Apr;18(2):406-14
pubmed: 24262029
ASAIO J. 2014 Jul-Aug;60(4):436-42
pubmed: 24814842
Am J Kidney Dis. 2014 Nov;64(5):685-95
pubmed: 25156305
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):39-46
pubmed: 25512646
Clin Nephrol. 2003 Aug;60(2):105-12
pubmed: 12940612
Adv Chronic Kidney Dis. 2007 Jul;14(3):e10-6
pubmed: 17603970
J Am Soc Nephrol. 2005 Jul;16(7):2162-9
pubmed: 15930095
J Am Soc Nephrol. 2003 Sep;14(9):2345-51
pubmed: 12937312
Clin Exp Nephrol. 2017 Apr;21(2):324-332
pubmed: 27125432
ASAIO J. 2018 Jan/Feb;64(1):77-85
pubmed: 28742531
Blood Purif. 2013;36(3-4):192-9
pubmed: 24496190
Hemodial Int. 2018 Apr;22(2):254-260
pubmed: 28762626
Hypertension. 2010 Feb;55(2):305-11
pubmed: 20038754
Contrib Nephrol. 2010;164:69-78
pubmed: 20427995
Artif Organs. 1993 Aug;17(8):691-4
pubmed: 8215949
Am J Nephrol. 2013;38(1):78-90
pubmed: 23838386
Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1730-1732
pubmed: 29018099
ASAIO J. 2014 Jul-Aug;60(4):452-8
pubmed: 24658520
Blood Purif. 2019;48 Suppl 1:1-6
pubmed: 31751990
Kidney Int. 2020 May;97(5):861-876
pubmed: 32278617
BMC Nephrol. 2019 Feb 11;20(1):47
pubmed: 30744587
Kidney Int. 1990 Aug;38(2):342-6
pubmed: 2205752
Blood Purif. 2013;35 Suppl 1:55-8
pubmed: 23466380
Int J Artif Organs. 2007 Jan;30(1):16-24
pubmed: 17295189
Int J Artif Organs. 1995 Sep;18(9):487-94
pubmed: 8582763
Hemodial Int. 2016 Jul;20(3):484-91
pubmed: 27061224
Circ Heart Fail. 2016 Aug;9(8):e002922
pubmed: 27436837
Hemodial Int. 2020 Jul;24(3):344-350
pubmed: 32115891
Nephrol Dial Transplant. 1998 Aug;13(8):2098-103
pubmed: 9719173
Blood Purif. 2014;38(3-4):180-7
pubmed: 25531533
Clin J Am Soc Nephrol. 2010 Jul;5(7):1255-60
pubmed: 20507951
Hemodial Int. 2016 Apr;20(2):321-6
pubmed: 26467262